Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Blackstone
Fierce Biotech
Merck bags $700M from Blackstone, spends $150M to regain asset
Merck is paying $150 million upfront for full control of an early-phase asset and pocketing $700 million to fund an expansive pivotal oncology push.
Nick Paul Taylor
Nov 4, 2025 9:15am
Trump policy, Pfizer, CMIC—Fierce Pharma Asia
Mar 7, 2025 8:05am
After M&A rumors, Bausch + Lomb confirms it's exploring a sale
Dec 12, 2024 11:26am
Happy Cringemas? Blackstone taps Swift’s Eras Tour for video
Dec 15, 2023 9:36am
Amicus scores $430M financing deal with asset manager Blackstone
Oct 2, 2023 4:16pm
Sanofi taps Blackstone for $300M for subcutaneous Sarclisa R&D
Mar 15, 2022 9:20am
